Skip to main content

Marex Group plc

Position in ABBV — AbbVie Inc.

CIK 1997464 London, X0

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,408,932
-$65,794,172 QoQ
Shares Held
5,599
-98.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,232
of 4,153 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$65,247,000
PutShares
300,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. ABBV ranks #7 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ABBV
AbbVie Inc.
This page
5,599 $1,408,932

All Filings in ABBV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,408,932 5,599
2026-03-31 $65,247,000 300,000
2026-03-31 $67,203,104 308,994
2025-12-31 $291,552 1,276
2025-09-30 $338,279 1,461
2025-06-30 $1,097,756 5,914
2025-03-31 $704,825 3,364
2024-12-31 $783,834 4,411
2024-09-30 $1,861,051 9,424
2024-06-30 $525,194 3,062
2024-03-31 $315,578 1,733
2023-12-31 $242,837 1,567
2023-03-31 $267,900 1,681
2022-12-31 $1,857,545 11,494